Clinical Trial Update: Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing periurethral versus intravaginal estrogen for preventing recurrent urinary tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Intravaginal estradiol (estradiol)
• Periurethral estradiol (estradiol)

Snippet

Sponsor: Stephanie Wang Zuo | Conditions: Recurrent Urinary Tract Infection | Phase 2 | Status: COMPLETED